Bleomycin in testicular teratomas
- PMID: 53948
- DOI: 10.1007/BF00312250
Bleomycin in testicular teratomas
Abstract
Bleomycin and its combinations have a definite place in the treatment of metastatic testicular carcinomas other than seminomas and may also prove to be effective, when given as adjuvant postoperative therapy in state II disease. A study, using the combination of Bleomycin and CCNU in 17 patients with metastatic testicular teratoma, is reported. A remission rate of 59% has been observed. Only patients with a complete remission had a satisfactory remission duration. Sequential combinations, using all drugs effective in this disease, may be the most promising way to further improve therapeutic results in terms of remission rate and survival.
Similar articles
-
[New chemotherapy (adriamycin, belomycin and vincristin) of metastasizing malignant testicular teratoma (author's transl)].Dtsch Med Wochenschr. 1975 Jun 13;100(24):1319-24. doi: 10.1055/s-0028-1106379. Dtsch Med Wochenschr. 1975. PMID: 48459 German.
-
Treatment of metastatic testicular carcinoma with bleomycin (NSC-125066) used alone or in combination with CCNU (NSC-79037).Cancer Chemother Rep. 1975 Mar-Apr;59(2 Pt 1):429-31. Cancer Chemother Rep. 1975. PMID: 50125 Clinical Trial. No abstract available.
-
The treatment of metastatic testicular tumors.J Urol. 1972 Sep;108(3):439-42. doi: 10.1016/s0022-5347(17)60765-1. J Urol. 1972. PMID: 4115279 No abstract available.
-
[Bilateral and synchronous testicular teratoma: a case report and literature review].Cir Cir. 2015 Nov-Dec;83(6):527-31. doi: 10.1016/j.circir.2015.05.035. Epub 2015 Jul 9. Cir Cir. 2015. PMID: 26164135 Review. Spanish.
-
A perspective on adjuvant chemotherapy of testicular cancer.J Cancer Res Clin Oncol. 1979 Sep;95(1):1-9. doi: 10.1007/BF00411103. J Cancer Res Clin Oncol. 1979. PMID: 387803 Free PMC article. Review. No abstract available.